HUM vs LMAT · P/E 39, rev $117.76B vs P/E 35, rev $219.9M
Humana Inc (HUM) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the HUM and LMAT stock pages for the full models.
Not investment advice.